During tumor progression, elevated cytokines (e.g., interleukin-6) and oxidative stress impair erythropoiesis, increase erythrocyte fragility, induce functional iron deficiency, and disrupt energy metabolism, thereby promoting the development of anemia (30). The gene discussed is IL6; the disease is neoplasm.